After earning his medical degree at the State University of New York Health Science Center at Brooklyn, Dr. Mark Levin has served for close to 30 years as an administrator, clinician, researcher, and author in the fields of hematology and oncology.
Using his extensive experience in breast cancer, neuro-oncology, genitourinary oncology, and Gaucher disease, he has fulfilled the role of Director or Chief at four different university hospitals and cancer centers, including at New Jersey Medical School and Weil-Cornell College of Medicine.
Dr. Levin has held the following positions over the past two decades:
- Interim Chief of Hematology and Oncology – New Jersey Medical School
- Cancer Center Director – Holy Name Hospital in Teaneck, NJ
- Chief of Hematology and Oncology and Chief of Service – Lincoln Medical Center
- Co-Director of Oncology – Brookdale University Hospital and Medical Center
- Affiliated with NYC Health + Hospitals Corporation
He is certified in Internal Medicine and Medical Oncology, obtained the Hematology certification, has an MBA and Board Certification in Quality Assurance and Utilization review, and has medical legal experience.
Dr. Levin completed residencies with New York University Downtown Hospital and the Drexel University Hahnemann University Hospital. He also completed his fellowship with North Shore-Long Island Jewish Health System.
He is the first author of over thirty academic articles, chapters, and books relating to various topics in hematology and oncology. Adding to his experience are his developing and running of two clinical research programs, a non-profit educational institution, and a consulting group.
Dr. Levin is well versed in mesothelioma, having advised many mesothelioma patients and their families. With the Mesothelioma Cancer Network, he will contribute his knowledge and share his expertise about this deadly cancer.